Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Harvard Business School
Medtronic
Dow

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

XELLIA PHARMS APS Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for XELLIA PHARMS APS
International Patents:31
US Patents:4
Tradenames:11
Ingredients:11
NDAs:16

Drugs and US Patents for XELLIA PHARMS APS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xellia Pharms Aps MICAFUNGIN SODIUM micafungin sodium INJECTABLE;INTRAVENOUS 211713-002 Jun 2, 2021 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-006 May 13, 2020 RX Yes Yes 10,849,956 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Xellia Pharms Aps CASPOFUNGIN ACETATE caspofungin acetate POWDER;INTRAVENOUS 205923-002 Jul 2, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 204107-002 Dec 28, 2015 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN vancomycin SOLUTION;INTRAVENOUS, ORAL 213895-001 Aug 26, 2021 RX Yes Yes 10,188,697 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for XELLIA PHARMS APS Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1115417 SPC/GB06/024 United Kingdom ⤷  Free Forever Trial SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB06/024 GRANTED TO CUBIST PHARMACEUTICALS, INC IN RESPECT OF THE PRODUCT DAPTOMYCIN, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6162 DATED 27 JUNE 2007 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 22 JANUARY 2021.
1280520 14/2015 Austria ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
1115417 22/2006 Austria ⤷  Free Forever Trial PRODUCT NAME: DAPTOMYCIN; REGISTRATION NO/DATE: EU/1/05/328/001 UND 002 20060119
0620232 C300076 Netherlands ⤷  Free Forever Trial PRODUCT NAME: CASPOFUNGINE, DESGEWENST IN DE VORM VAN EEN ZUURADDITIEZOUT, IN HET BIJZONDER CASPOFUNGINE ACETAAT; REGISTRATION NO/DATE: EU/1/01/196/001-003 20011024
0788511 08C0028 France ⤷  Free Forever Trial PRODUCT NAME: MICAFUNGINE; REGISTRATION NO/DATE: EU/1/08/448/001-002 20080425
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Colorcon
Baxter
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.